(Q45780381)

16 December 2017

title

Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis (English)

1 reference

16 December 2017

author name string

Shiu-Chung Au

1

1 reference

16 December 2017

Ari M Goldminz

2

1 reference

16 December 2017

Noori Kim

3

1 reference

16 December 2017

Nicole Dumont

4

1 reference

16 December 2017

Melissa Michelon

5

1 reference

16 December 2017

Eva Volf

6

1 reference

16 December 2017

Meghan Hession

7

1 reference

16 December 2017

Paul F Lizzul

8

1 reference

16 December 2017

Israel D Andrews

9

1 reference

16 December 2017

Todd Kerensky

10

1 reference

16 December 2017

Andrew Wang

11

1 reference

16 December 2017

Shimrat Yaniv

12

1 reference

16 December 2017

Alice B Gottlieb

13

1 reference

16 December 2017

publication date

8 May 2012

1 reference

16 December 2017

Journal of Dermatological Treatment

published in

1 reference

16 December 2017

volume

24

1 reference

16 December 2017

issue

3

1 reference

16 December 2017

page(s)

179-187

1 reference

16 December 2017

Palmoplantar psoriasis: a phenotypical and clinical review with introduction of a new quality-of-life assessment tool

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

A classification of psoriasis vulgaris according to phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

Management of difficult to treat locations of psoriasis. Scalp, face, flexures, palm/soles and nails

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

Palmoplantar lesions in psoriasis: a study of 3065 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

Evaluation of topical 0.1% tazarotene cream in the treatment of palmoplantar psoriasis: an observer-blinded randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

Topical vitamin D3 derivatives in treating hyperkeratotic palmoplantar eczema: a report of five patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

Efalizumab for severe palmo-plantar psoriasis: an open-label pilot trial in five patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

Treatment of palmoplantar psoriasis with intramuscular alefacept.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

Psoriasis--clinical features.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

Pustulosis palmoplantaris is a disease distinct from psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

The relationships of onset and exacerbation of pustulosis palmaris et plantaris to smoking and focal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

Extra-palmoplantar lesions associated with palmoplantar pustulosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

Genetic Analysis of PSORS1 Distinguishes Guttate Psoriasis and Palmoplantar Pustulosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

Association analysis of IL19, IL20 and IL24 genes in palmoplantar pustulosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

Palmoplantar pustulosis treated with itraconazole: a single, active-arm pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

Therapeutic options for palmoplantar pustulosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

Oral liarozole in the treatment of palmoplantar pustular psoriasis: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

How good are clinical severity and outcome measures for psoriasis?: quantitative evaluation in a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

The outcomes movement and new measures of the severity of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

Quality of life measures in psoriasis: a critical appraisal of their quality

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

Association of TNF -238 and -308 Promoter Polymorphisms with Psoriasis Vulgaris and Psoriatic Arthritis but not with Pustulosis Palmoplantaris

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

Evaluation of Tonsillectomy as a Treatment for Pustulosis Palmaris Et Plantarts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09546634.2012.672710

10.3109/09546634.2012.672710

21 January 2018

Identifiers

DOI

1 reference

16 December 2017

1 reference

16 December 2017